D.B. Rylatt

1.5k total citations
33 papers, 1.3k citations indexed

About

D.B. Rylatt is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, D.B. Rylatt has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in D.B. Rylatt's work include Blood properties and coagulation (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Protein purification and stability (6 papers). D.B. Rylatt is often cited by papers focused on Blood properties and coagulation (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Protein purification and stability (6 papers). D.B. Rylatt collaborates with scholars based in Australia, United States and Israel. D.B. Rylatt's co-authors include Peter Bundesen, M J Elms, A.N. Whitaker, Paul P. Masci, Ian Bunce, A. J. Webber, M. J. Waters, Ross Barnard, Andrea Blake and William A. Fletcher and has published in prestigious journals such as The Lancet, Biochemical Journal and Journal of Chromatography A.

In The Last Decade

D.B. Rylatt

33 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.B. Rylatt Australia 18 386 376 360 286 223 33 1.3k
A.N. Whitaker Australia 21 529 1.4× 501 1.3× 355 1.0× 300 1.0× 155 0.7× 39 1.5k
N. A. Booth United Kingdom 27 544 1.4× 1.1k 2.8× 151 0.4× 202 0.7× 426 1.9× 64 2.1k
Paul Didisheim United States 25 436 1.1× 694 1.8× 148 0.4× 430 1.5× 171 0.8× 98 1.8k
Jolán Hársfalvi Hungary 22 312 0.8× 526 1.4× 76 0.2× 152 0.5× 215 1.0× 84 1.5k
Alan J. Johnson United States 16 454 1.2× 603 1.6× 135 0.4× 135 0.5× 212 1.0× 43 1.5k
Jang Soo Suh South Korea 27 421 1.1× 909 2.4× 73 0.2× 106 0.4× 224 1.0× 126 2.2k
Gabriela Cesarman‐Maus Mexico 13 194 0.5× 424 1.1× 349 1.0× 189 0.7× 275 1.2× 31 1.3k
E.T. Yin United States 16 205 0.5× 539 1.4× 565 1.6× 445 1.6× 188 0.8× 32 1.6k
Kenneth D. Friedman United States 33 178 0.5× 2.0k 5.3× 287 0.8× 472 1.7× 159 0.7× 98 3.0k
Jonathan H. Foley Canada 20 212 0.5× 588 1.6× 163 0.5× 152 0.5× 252 1.1× 37 1.6k

Countries citing papers authored by D.B. Rylatt

Since Specialization
Citations

This map shows the geographic impact of D.B. Rylatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.B. Rylatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.B. Rylatt more than expected).

Fields of papers citing papers by D.B. Rylatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.B. Rylatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.B. Rylatt. The network helps show where D.B. Rylatt may publish in the future.

Co-authorship network of co-authors of D.B. Rylatt

This figure shows the co-authorship network connecting the top 25 collaborators of D.B. Rylatt. A scholar is included among the top collaborators of D.B. Rylatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.B. Rylatt. D.B. Rylatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rylatt, D.B., et al.. (2003). Preparation of Monoclonal Antibodies Using the Electrophoresis Separation Instrument, Gradiflow™. PubMed. 22(1). 47–53. 1 indexed citations
2.
Shave, Evan, et al.. (2002). Preparative electrophoresis: a general method for the purification of polyclonal antibodies. Journal of Chromatography A. 944(1-2). 161–168. 29 indexed citations
3.
Rylatt, D.B., et al.. (1999). Electrophoretic transfer of proteins across polyacrylamide membranes. Journal of Chromatography A. 865(1-2). 145–153. 39 indexed citations
4.
Lim, Sian Yik, et al.. (1998). Purification of monoclonal antibodies from ascitic fluid using preparative electrophoresis. Journal of Chromatography A. 827(2). 329–335. 23 indexed citations
5.
Eisenberg, Richard, D.B. Rylatt, F Rusticali, et al.. (1997). The importance of antibody specificity in measuring cross-linked fibrin degradation products by ELISA. Blood Coagulation & Fibrinolysis. 8(2). 105–113. 6 indexed citations
6.
Pery, Menucha, N. Lanir, A. L. Markel, et al.. (1995). Application of a bedside whole blood D-dimer assay in the diagnosis of deep vein thrombosis. Blood Coagulation & Fibrinolysis. 6(3). 219–222. 35 indexed citations
7.
Elms, M J, et al.. (1993). Automated determination of cross-linked fibrin derivatives in plasma. Blood Coagulation & Fibrinolysis. 4(1). 159–164. 7 indexed citations
8.
Boniface, G. R., et al.. (1993). Technetium‐99 m labelling of DD‐3B6/22 antifibrin monoclonal antibody fragment Fab′ for thrombus imaging. Immunology and Cell Biology. 71(2). 117–124. 8 indexed citations
9.
Boniface, G. R., et al.. (1992). Evaluation of thrombus detection in a rabbit model using a technetium‐99M‐labelled anti‐fibrin monoclonal antibody. Immunology and Cell Biology. 70(3). 173–179. 8 indexed citations
10.
Bundesen, Peter, S. Martin, Gordon H. Dixon, et al.. (1990). An evaluation of the VetREDTM canine heartworm antigen test.. 20(3). 144–149. 3 indexed citations
11.
Elms, M J, et al.. (1990). The simpliRED D dimer test: A novel assay for the detection of crosslinked fibrin degradation products in whole blood. Thrombosis Research. 58(3). 273–281. 67 indexed citations
12.
Walker, F. J., et al.. (1988). Anti-fibrin monoclonal antibodies for radioimmunodetection : preliminary assessment in a rat model system. Australian and New Zealand Journal of Medicine. 18(3). 490. 1 indexed citations
13.
Walker, Karen Z., Frederick Khafagi, George J. Bautovich, et al.. (1988). Anti-fibrin monoclonal antibodies for radioimmunodetection : Preliminary assessment in a rat model system. Thrombosis Research. 52(4). 269–278. 4 indexed citations
14.
Khoo, S. K., D.B. Rylatt, Peter G. Parsons, et al.. (1988). Serial D-dimer levels in the assessment of tumor mass and clinical outcome in ovarian cancer. Gynecologic Oncology. 29(2). 188–198. 16 indexed citations
15.
Wood, P.R., Jan Ripper, Anthony J. Radford, et al.. (1988). Production and Characterization of Monoclonal Antibodies Specific for Mycobacterium bovis. Microbiology. 134(9). 2599–2604. 38 indexed citations
16.
Whitaker, A.N., Ian Bunce, Ralph Cobcroft, et al.. (1987). Measurement of Crosslinked Fibrin Derivatives -Use in the Diagnosis of Venous Thrombosis. Thrombosis and Haemostasis. 57(1). 59–61. 125 indexed citations
17.
Vankan, D., et al.. (1987). Use of an antigen detection assay to determine mortality of Dirofilaria immitis after thiacetarsamide therapy. Australian Veterinary Journal. 64(3). 76–78. 1 indexed citations
18.
Bundesen, Peter, David M. Wyatt, Andrea Blake, et al.. (1985). Monoclonal antibodies directed against cell surface antigens. Veterinary Immunology and Immunopathology. 8(3). 245–260. 15 indexed citations
19.
Whitaker, A.N., M J Elms, Paul P. Masci, et al.. (1984). Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.. Journal of Clinical Pathology. 37(8). 882–887. 133 indexed citations
20.
Rylatt, D.B., Andrea Blake, William A. Fletcher, et al.. (1983). An immunoassay for human D dimer using monoclonal antibodies. Thrombosis Research. 31(6). 767–778. 282 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026